| Suggesting 7, 8-dihydroxyflavone as a promising nutraceutical against CNS disorders R Paul, J Nath, S Paul, MK Mazumder, BC Phukan, R Roy, ... Neurochemistry International 148, 105068, 2021 | 15 | 2021 |
| Targeting the Pathological Hallmarks of Alzheimer’s Disease Through Nanovesicleaided Drug Delivery Approach R Roy, P Bhattacharya, A Borah Current Drug Metabolism 23 (9), 693-707, 2022 | 7 | 2022 |
| Resveratrol as a therapeutic choice for traumatic brain injury: An insight into its molecular mechanism of action J Nath, R Roy, YK Sathyamoorthy, S Paul, S Goswami, H Chakravarty, ... Brain Disorders 6, 100038, 2022 | 7 | 2022 |
| Garcinia morella extract confers dopaminergic neuroprotection by mitigating mitochondrial dysfunctions and inflammation in mouse model of Parkinson’s disease A Dutta, BC Phukan, R Roy, MK Mazumder, R Paul, A Choudhury, ... Metabolic Brain Disease 37 (6), 1887-1900, 2022 | 4 | 2022 |
| Traversing through the cell signaling pathways of neuroprotection by betanin: Therapeutic relevance to Alzheimer’s Disease and Parkinson’s Disease BC Phukan, R Roy, R Paul, MK Mazumder, J Nath, P Bhattacharya, ... Metabolic Brain Disease 38 (3), 805-817, 2023 | 3 | 2023 |
| Assessment of Mitochondrial Complex II and III Activity in Brain Sections: A Histoenzymological Technique R Roy, R Paul, P Bhattacharya, A Borah Mitochondria: Methods and Protocols, 73-81, 2022 | | 2022 |
